Previous close | 212.30 |
Open | 213.90 |
Bid | 212.80 x 0 |
Ask | 213.10 x 0 |
Day's range | 209.50 - 214.90 |
52-week range | 139.55 - 245.40 |
Volume | |
Avg. volume | 604,696 |
Market cap | 62.927B |
Beta (5Y monthly) | 0.49 |
PE ratio (TTM) | 25.00 |
EPS (TTM) | 8.53 |
Earnings date | 19 July 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 250.50 |
Apellis' (APLS) earnings missed estimates in the first quarter of 2022, while revenues surpassed expectations.
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter of 2022
Swedish Orphan Biovitrum AB (publ) (Sobi®) has released the company's 2021 Annual and Sustainability Report. The integrated report summarises business and strategy, financial performance and work on sustainability.